These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 3166546)

  • 1. Nephrotoxicity in leukemic patients receiving empirical amphotericin B and aminoglycosides.
    Stein RS; Albridge K; Lenox RK; Ray W; Flexner JM
    South Med J; 1988 Sep; 81(9):1095-9. PubMed ID: 3166546
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sodium protects against nephrotoxicity in patients receiving amphotericin B.
    Stein RS; Alexander JA
    Am J Med Sci; 1989 Nov; 298(5):299-304. PubMed ID: 2683769
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amphotericin-B nephrotoxicity in humans decreased by sodium supplements with coadministration of ticarcillin or intravenous saline.
    Branch RA; Jackson EK; Jacqz E; Stein R; Ray WA; Ohnhaus EE; Meusers P; Heidemann H
    Klin Wochenschr; 1987 Jun; 65(11):500-6. PubMed ID: 3475498
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention of amphotericin B-induced renal impairment. A review on the use of sodium supplementation.
    Branch RA
    Arch Intern Med; 1988 Nov; 148(11):2389-94. PubMed ID: 3056312
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retrospective review of vancomycin-induced nephrotoxicity in patients with leukemia.
    Fullmer A; McCue D; Feng C
    J Oncol Pharm Pract; 2014 Dec; 20(6):403-8. PubMed ID: 24177356
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Prevention of nephrotoxicity of amphotericin B during the treatment of deep candidiasis].
    Jacqz E; Branch RA; Heidemann H; Aujard Y
    Ann Biol Clin (Paris); 1987; 45(6):689-93. PubMed ID: 3326441
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of fluid and electrolyte management on amphotericin B-induced nephrotoxicity among extremely low birth weight infants.
    Holler B; Omar SA; Farid MD; Patterson MJ
    Pediatrics; 2004 Jun; 113(6):e608-16. PubMed ID: 15173544
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of sodium in protection by extended-spectrum penicillins against tobramycin-induced nephrotoxicity.
    Sabra R; Branch RA
    Antimicrob Agents Chemother; 1990 Jun; 34(6):1020-5. PubMed ID: 2393261
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of low-dose dopamine in preventing amphotericin B nephrotoxicity in bone marrow transplant patients and leukemia patients.
    Camp MJ; Wingard JR; Gilmore CE; Lin LS; Dix SP; Davidson TG; Geller RB
    Antimicrob Agents Chemother; 1998 Dec; 42(12):3103-6. PubMed ID: 9835498
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevention of amphotericin-B-induced nephrotoxicity by loading with sodium chloride: a report of 1291 days of treatment with amphotericin B without renal failure.
    Arning M; Scharf RE
    Klin Wochenschr; 1989 Oct; 67(20):1020-8. PubMed ID: 2586007
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibiotic combination-associated nephrotoxicity in granulocytopenic patients with cancer.
    Wade JC; Schimpff SC; Wiernik PH
    Arch Intern Med; 1981 Dec; 141(13):1789-93. PubMed ID: 6797359
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk factors for Amphotericin B-associated nephrotoxicity.
    Fisher MA; Talbot GH; Maislin G; McKeon BP; Tynan KP; Strom BL
    Am J Med; 1989 Nov; 87(5):547-52. PubMed ID: 2816970
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Do vancomycin serum levels predict failures of vancomycin therapy or nephrotoxicity in cancer patients?
    Kralovicová K; Spanik S; Halko J; Netriova J; Studena-Mrazova M; Novotny J; Grausova S; Koren P; Krupova I; Demitrovicova A; Kukuckova E; Krcmery V
    J Chemother; 1997 Dec; 9(6):420-6. PubMed ID: 9491842
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Implementation of clinical practice policy on the continuous intravenous administration of amphotericin B deoxycholate.
    Maharom P; Thamlikitkul V
    J Med Assoc Thai; 2006 Nov; 89 Suppl 5():S118-24. PubMed ID: 17718252
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amphotericin B nephrotoxicity in humans decreased by salt repletion.
    Heidemann HT; Gerkens JF; Spickard WA; Jackson EK; Branch RA
    Am J Med; 1983 Sep; 75(3):476-81. PubMed ID: 6614033
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical experience with amphotericin B in acute myelogenous leukemia.
    Stein RS; Greer JP; Ferrin W; Lenox R; Baer MR; Flexner JM
    South Med J; 1986 Jul; 79(7):863-70. PubMed ID: 3460180
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of aminoglycosides during cyclosporine A immunosuppression after liver transplantation in children.
    Leach CT; Kuhls TL; Brill JE; Busuttil RW; Cherry JD
    Pediatr Infect Dis J; 1989 Jun; 8(6):354-7. PubMed ID: 2664691
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nephrotoxicity of vancomycin, alone and with an aminoglycoside.
    Rybak MJ; Albrecht LM; Boike SC; Chandrasekar PH
    J Antimicrob Chemother; 1990 Apr; 25(4):679-87. PubMed ID: 2351627
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mississippi mud no more: cost-effectiveness of pharmacokinetic dosage adjustment of vancomycin to prevent nephrotoxicity.
    Darko W; Medicis JJ; Smith A; Guharoy R; Lehmann DE
    Pharmacotherapy; 2003 May; 23(5):643-50. PubMed ID: 12741439
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nephrotoxicity of aminoglycosides, polypeptides and cephalosporins in cancer patients.
    Krcméry V; Fuchsberger P; Gocár M; Salát T; Bodnárová J; Sobota R; Koza I; Svec J
    Chemotherapy; 1991; 37(4):287-91. PubMed ID: 1790727
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.